Evidence map›Paper›PMID 32524514›Full record

ArticleInfection2020

Management of children with fever and neutropenia: results of a survey in 51 pediatric cancer centers in Germany, Austria, and Switzerland.

Max Scheler, Thomas Lehrnbecher, Andreas H Groll, Ruth Volland, Hans-Jürgen Laws, Roland A Ammann, Philipp Agyeman, Andishe Attarbaschi, Margaux Lux, Arne Simon

Open access · hybridAbstract read
In one paragraph

Article in Infection, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Etiology and Factors Affecting Severe Complications and Mortality of Febrile Neutropenia in Children with Acute LeukemiaTurkish journal of haematology : official journal of Turkish Society of Haematology · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 3 countries.

Max SchelerDepartment of Pediatric Oncology and Hematology, Medical Faculty, University Children's Hospital of Cologne, Cologne, Germany.
Thomas LehrnbecherPediatric Hematology and Oncology, Hospital for Children and Adolescents, University Hospital, Goethe University Frankfurt am Main, Frankfurt, Germany.
Andreas H GrollDepartment of Pediatric Oncology, Hematology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany.
Ruth VollandDepartment of Pediatric Oncology and Hematology, Medical Faculty, University Children's Hospital of Cologne, Cologne, Germany.
Hans-Jürgen LawsInfectious Disease Research Program, Center for Bone Marrow Transplantation and Department of Pediatric Hematology/Oncology, University Children's Hospital Münster, Münster, Germany.
Roland A AmmannDivision of Pediatric Hematology/Oncology, Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Philipp AgyemanDivision of Pediatric Hematology/Oncology, Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Andishe AttarbaschiPediatric Hematology and Oncology, St. Anna Children's Hospital, Medical University of Vienna, Vienna, Austria.
Margaux LuxPediatric Oncology and Hematology, Childrens' Hospital Medical Center, Saarland University Clinic, Kirrberger Str. Building 09, 66421, Homburg, Germany.
Arne SimonPediatric Oncology and Hematology, Childrens' Hospital Medical Center, Saarland University Clinic, Kirrberger Str. Building 09, 66421, Homburg, Germany. Arne.Simon@uks.eu.ORCID http://orcid.org/0000-0001-9558-3330
Saarland University · DEUniversity Hospital Cologne · DEUniversity of Bern · CHDüsseldorf University Hospital · DEGoethe University Frankfurt · DESt Anna Children's Hospital · ATUniversity Hospital Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeInvestigation of the current practice of diagnostics and treatment in pediatric cancer patients with febrile neutropenia.

methodsOn behalf of the German Society for Pediatric Oncology and Hematology and the German Society for Pediatric Infectious Diseases, an Internet-based survey was conducted in 2016 concerning the management of febrile neutropenia in pediatric oncology centers (POC). This survey accompanied the release of the corresponding German guideline to document current practice before its implementation in clinical practice.

resultsIn total, 51 POCs participated (response rate 73%; 43 from Germany, and 4 each from Austria and Switzerland). Identified targets for antimicrobial stewardship concerned blood culture diagnostics, documentation of the time to antibiotics, the use of empirical combination therapy, drug monitoring of aminoglycosides, the time to escalation in patients with persisting fever, minimal duration of IV treatment, sequential oral treatment in patients with persisting neutropenia, indication for and choice of empirical antifungal treatment, and the local availability of a pediatric infectious diseases consultation service.

conclusionThis survey provides useful information for local antibiotic stewardship teams to improve the current practice referring to the corresponding national and international guidelines.

Indexed as

Antimicrobial StewardshipAdolescentAustriaCancer Care FacilitiesChildChild, PreschoolFeverGermanyHumansInfantInfant, NewbornNeoplasmsNeutropeniaSwitzerlandAntimicrobial treatmentFebrile neutropeniaPediatric cancer patientsSurvey

Identifiers

PMID32524514
PMCPMC7395019
OpenAlexW3034133531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.